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ABSTRACT 
 
Identification of Protein Targets of Nevirapine Reactive Metabolites using 
Click Chemistry and Mass Spectrometry-Based Differential Proteomics 
par 
Ghada Eloraby 
Département de pharmacologie 
 
Mémoire présenté à la Faculté de Médecine et des Sciences de la Santé en vue de 
l'obtention du grade de Maître ès Sciences (M. Sc.) en pharmacologie 
Faculté de médecine et des sciences de la santé, Université de Sherbrooke, 
Sherbrooke, Québec, Canada, J1H 5N4 
 
 
Adverse drug reactions (ADRs) are undesirable effects caused after administration of a 
single dose or prolonged administration of drug or result from the combination of two or 
more drugs.  Idiosyncratic drug reaction (IDR) is an adverse reaction that does not occur in 
most patients treated with a drug and does not involve the therapeutic effect of the drug. 
IDRs are unpredictable and often life-threatening. Idiosyncratic reaction is dependent on 
drug chemical characteristics or individual immunological response. IDRs are a major 
problem for drug development because they are usually not detected during clinical trials. 
  
In this study we focused on IDRs of Nevirapine (NVP), which is a non-nucleoside reverse 
transcriptase inhibitor used for the treatment of Human Immunodeficiency Virus (HIV) 
infections. The use of NVP is limited by a relatively high incidence of skin rash. NVP also 
causes a rash in female Brown Norway (BN) rats, which we use as animal model for this 
study. Our hypothesis is that idiosyncratic skin reactions associated with NVP treatment 
are due to post-translational modifications of proteins (e.g., glutathionylation) detectable by 
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MS. The main objective of this study was to identify the proteins that are targeted by a 
reactive metabolite of Nevirapine in the skin. 
 
The specific objectives derived from the general objective were as follow: 
1) To implement the click chemistry approach to detect proteins modified by a reactive 
NVP-Alkyne (NVP-ALK) metabolite. The purpose of using NVP-ALK was to couple 
it with Biotin using cycloaddition Click Chemistry reaction. 
2) To detect protein modification using Western blotting and Mass Spectrometry 
techniques, which is important to understand the mechanism of NVP induced toxicity. 
3) To identify the proteins using MASCOT search engine for protein identification, by 
comparing obtained spectrum from Mass Spectrometry with theoretical spectrum to 
find a matching peptide sequence.  
4) To test if the drug or drug metabolites can cause harmful effects, as the induction of 
oxidative stress in cells (via protein glutathionylation). Oxidative stress causes cell 
damage that mediates signals, which likely induces the immune response. 
 
The results showed that Nevirapine is metabolized to a reactive metabolite, which causes 
protein modification. The extracted protein from the treated BN rats matched 10% of 
keratin, which implies that keratin was the protein targeted by the NVP-ALK. 
 
Key words: Nevirapine, HIV, IDR, Hypersensitivity, Click chemistry, Brown Norway rat, 
Western blotting, danger hypothesis. 
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Résumé 
 
Les effets indésirables (EI) sont les effets indésirables causés après l'administration d'une 
dose unique ou une administration prolongée du médicament ou le résultat de la 
combinaison de deux médicaments ou plus. La Réaction idiosyncratique (IDR) est une 
réaction indésirable qui ne se produit pas dans la plupart des patients traités avec un 
médicament et qui ne comporte pas l'effet thérapeutique du médicament. IDR sont 
imprévisibles et peuvent mettre la vie du malade en danger. Cette réaction dépend des 
caractéristiques chimiques du médicaments et/ou de la réponse immunitaire individuelle du 
patient. IDR est un problème majeur pour le développement de médicaments car ils ne sont 
généralement pas détectés au cours des essais cliniques. 
 
Dans cette étude, nous nous sommes concentrés sur la Réaction idiosyncratique de 
névirapine (NVP) qui est un inhibiteur de transcriptase inverse non nucléosidique utilisé 
pour le traitement du virus d'immunodéficience humaine (VIH). L'utilisation de NVP est 
limitée par une incidence relativement élevée d'éruption cutanée. NVP provoque également 
une éruption cutanée chez les rats femelles de souche Brown Norway. Notre étude vise à 
mieux comprendre les IDRs induites par l'administration de NVP chez l'animal. La présente 
étude vise à vérifier l'hypothèse que les problèmes cutanés associés à la prise de NVP 
soient attribuables à la modification post-traductionnelle de protéines détactable par 
spectrométrie de masse. Les principaux objectifs de ce projet étaient : 
1) Déterminer si la Nevirapine alcynes (NVP-ALK), un analogue de la NVP peut 
développer la même éruption cutanée que la NVP. La NVP-ALK a été couplé avec 
de la biotine en utilisant la réaction chimique (click chemistry). 
2) Détecter les modifications post-traductionelles des proteines par Western blot et des 
techniques de spectrométrie de masse, pour comprendre le mécanisme de la toxicité 
induite par la NVP. 
3) Identifier les protéines modifiées en utilisant le moteur de recherche MASCOT pour 
l'identification des protéines, en comparant le les spectres de masse obtenus avec les 
spectres théoriques pour trouver une séquence correspondante de peptide. 
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4) Tester si la NVP et ses métabolites peuvent provoquer des effets nocifs, comme 
l'induction d'un stress oxydatif dans les cellules (par la mesure de la 
glutathionylation des protéines). 
 
Les résultats ont montré que la névirapine est métabolisé en métabolite réactif ce qui 
provoque une modification de la kératine. Ainsi nos résultats suggèrent que la kératine est 
la cible des métabolites de la NVP-ALK. 
 
Mots clés : Névirapine, VIH, IDR, Hypersensibilité, chimie Click, Brown Norway rat, 
Western blot, spectrométrie de masse et stress oxidatif. 
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CHAPTER 1 
INTRODUCTION 
 
1.1 HIV and AIDS 
Acquired Immunodeficiency Syndrome (AIDS) is caused by the Human Immunodeficiency 
Virus (HIV). The HIV is a retrovirus single stranded RNA virus characterized by a 
long incubation period. It infects vital cells in the human immune system such as T-helper 
cells, macrophages, and dendritic cells (Cunningham et al., 2010). HIV causes damage to 
all attacked cells and makes it impossible for the cells to function normally, even though 
the cells remain alive for a period. Overtime, the virus can develop into AIDS if untreated.  
 
According to the World Health Organization (WHO), an estimated 2.0 million individuals 
worldwide were infected with HIV in 2014.  This number included over 220,000 children 
(less than 15 years). Most of these children live in sub-Saharan Africa and were infected by 
their HIV-positive mothers during pregnancy, childbirth or breastfeeding. By the end of 
2014, there were approximately 36.9 million people worldwide living with HIV/AIDS, 2.6 
million were children. In addition, according to the WHO, an estimated 34 million people 
have died from AIDS-related causes so far, including 1.2 million in 2014. Furthermore, 
despite advances in the scientific understanding of HIV and its prevention and treatment as 
well as the efforts of the global health community and leading government and civil society 
organizations, most people living with HIV or at risk for HIV do not have access to 
prevention, care, and treatment, and there is still no cure (AIDS.gov, 2015). 
 
Chapter 1: Introduction 
2 
Typically, HIV and AIDS carriers can no longer fight off infection. This leaves the immune 
system open to harmful diseases such as cancer. Thus, global efforts have been mounted to 
reduce the HIV infection rates and address the HIV epidemic. In addition, the number of 
people with HIV receiving treatment in resource-poor countries has dramatically increased 
in the past decade. According to the Joint United Nations Programme on HIV/AIDS 
(UNAIDS, 2016), in June 2015, 15.8 million people living with HIV were accessing 
antiretroviral therapy (ART) globally. In fact, 73% of the estimated 1.5 million pregnant 
women living with HIV globally were able to access it to avoid transmitting the HIV to 
their children (UNAIDS, 2016). 
 
According to Public Health Agency of Canada (2015), the HIV incidence, prevalence, and 
proportion undiagnosed in 2014, were estimated as follows:   
 There were approximately 1396 cases of infections in 2014 attributed to the men who 
have sex with men, representing 54.3% of all new infections.  
 There was an estimate of 270 new infections in 2014 attributed to injection drug use 
(IDU) exposure. 
 The number of new infections attributed to the combined heterosexual contact 
exposure categories (non-endemic and endemic) was 839. 
 
1.2 HIV and AIDS Treatment 
There is no cure for the common virus. However, one can use self-treatment methods to 
strengthen the immune system. It is important to get treatment immediately after detection. 
A consideration of the replicative cycle of the human immunodeficiency virus (HIV) can 
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lead to the identification of several steps that represent potential targets for antiretroviral 
therapy, and several substances that can inhibit the replication of HIV in vitro have already 
been identified (Yarchoan and Broder, 1987). 
 
HIV can be treated with antiretroviral drugs. They work on different stages of virus life 
cycle and can be summarized in the following four stages: 
1. Fusion inhibitors: inhibit virus entry/fusion.  
2. Reverse-transcriptase inhibitors (RTIs): inhibit reverse transcription of viral RNA to 
viral DNA. 
3. Integrase inhibitors (also known as integrase strand transfer inhibitors, INSTI): 
inhibit viral DNA integration with T-helper cell DNA. 
4. Protease inhibitors (PIs): inhibit protein synthesis and new virus assembly.  
 
The most significant issue about antiretroviral drugs is that they are associated with adverse 
side reactions. These reactions are known as idiosyncratic drug reactions. 
 
1.3 Idiosyncratic Drug Reactions 
Adverse drug reaction (ADR) is an injury caused by taking medication (Guideline for Good 
Clinical Practice, 1996). ADRs may occur following a single dose or prolonged 
administration of a drug or result from the combination of two or more drugs. The meaning 
of this expression differs from the meaning of "side effect", as this last expression might 
also imply that the effects can be beneficial (Nebeker et al., 2004).  ADRs remain an 
important cause of hospitalizations, and are associated with fatal cases every year (Patel 
and Marfatia, 2008). ADRs can also delay treatment and increase cost of patient care. 
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Factors induce adverse drug reaction are age, gender, polypharmacy (multiple drugs), 
pregnancy, breastfeeding and drug allergy.  
 
ADRs are classified into two basic types: Type A and Type B (Pirmohamed et al., 1998). 
Type A adverse reactions are common, predictable, dose dependent, can be detected in 
clinical trials (phase I-II), and can be detected in animals if an model for the drug in 
question is available. In addition, Type A represents about 80% of adverse reactions. On 
the other hand, Type B adverse drug reactions are known as (IDRs), they are uncommon, 
unpredictable, in some cases they are immune mediated, variable and severe. 
Unfortunately, without a valid animal model, it is practically impossible to determine 
whether a specific reactive metabolite is responsible for a given IDR. Given their 
unpredictable nature, IDRs are generally not detected until the drug is released onto the 
market because clinical trials involve a limited number of subjects (Attia, 2010). 
 
IDRs appear to not be concentration dependent (Uetrecht, 2003). A minimal amount of 
drug will cause an immune response, but it is suspected that at a low enough concentration, 
a drug will be less likely to initiate an immune response. However, in adverse drug 
reactions involving overdoses, the toxic effect is simply an extension of the 
pharmacological effect. On the other hand, clinical symptoms of idiosyncratic drug 
reactions are different than the pharmacological effect of the drug. 
 
IDRs pose a significant clinical threat and hamper drug development. The idiosyncratic 
nature of these reactions has made mechanistic studies exceedingly difficult, and yet 
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without a better understanding of the mechanisms involved it is unlikely that much progress 
can be made in dealing with the problem. 
 
It is worth mentioning that, unpredictable ADRs that occur in small percentage of patients, 
can be life-threatening. They may lead to death in some cases. Very little is understood 
about the mechanism of IDRs and their unpredictable nature makes them very difficult to 
study. There is a large amount of circumstantial evidence that most are immune-mediated 
and are caused by chemically reactive metabolites of the drugs involved rather than to the 
drug itself (Uetrecht, 2014). 
 
There are some drugs known by their severe and unpredictable adverse reactions, as 
mentioned before, and their reactions differ from one host to another such as the antiviral 
drugs. The antiviral drugs, however, do not share the same adverse reactions. They lead to 
non-adherence significant morbidity and treatment failure, consequently, the IDRs remain a 
challenge. 
 
Nevirapine (NVP), also marketed under the trade name Viramune (Boehringer Ingelheim), 
is a non-nucleoside reverse transcriptase inhibitor (NNRTI) used to treat HIV-1 infection 
and AIDS. The most common adverse effect of nevirapine is the development of mild or 
moderate rash (13%) (Viramune, 2014; Facts sheet from AIDS TDN, 2014). Severe or life-
threatening skin reactions have been observed in 1.5% of patients, including Stevens-
Johnson syndrome, toxic epidermal necrolysis and hypersensitivity. 
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Severe and life-threatening skin reactions, including fatal cases, have been reported. These 
have included cases of Stevens-Johnson syndrome, toxic epidermal necrolysis, and 
hypersensitivity reactions characterized by rash, constitutional findings, and organ 
dysfunction. 
 
Women tended to be at greater risk of Nevirapine-associated rash. Rash was reported in 
about half of patients with symptomatic hepatic side effects.  
1. Very common (10% or more): Rash (including maculopapular erythematous 
cutaneous eruptions, with or without pruritus). 
2. Common (1% to 10%): Moderate or severe rash (including rash, maculopapular 
rash, erythema nodosum, erythematous rash, papular rash, skin reaction, Stevens-
Johnson syndrome, drug rash with eosinophilia and systemic symptoms; up to 7%). 
 
1.3.1 Hapten hypothesis  
 Hapten hypothesis states that a reactive metabolite binds to protein making it foreign by 
inducing an immune response that in some cases leads to an adverse reaction. Landsteiner 
and Jacobs first introduced the theory behind the hapten hypothesis in 1935 (Landsteiner 
and Jacobs, 1935). The reactive molecule that binds to protein leading to an immune 
response is referred to as a hapten (Figure 1). This theory is based on the fact that drugs are 
thought to be too small to stimulate an immune response. They would therefore need to 
bind to a protein (hapten hypothesis), or to be metabolized to a protein reactive metabolite 
(prohapten hypothesis) to sensitize the immune system (Park et al., 2001).  
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Figure 1: Hapten hypothesis 
 
Hapten hypothesis states that drugs may convert to reactive metabolites, which can then 
bind to protein and cause protein modification. The modified proteins can then trigger an 
immune response and induce IDRs. One drug molecule that responded to this hypothesis 
was Penicillin. It was found that the β-lactam ring of penicillin reacts irreversibly with free 
amino and sulfhydryl groups of proteins. In some patients, this leads to an immune 
response against the penicillin–protein adduct, and if the antibody response generates 
sufficient IgE antibodies, a severe allergic reaction such as anaphylaxis can result (Parker 
and Thiel, 1963). There are also minor breakdown products of penicillin that can covalently 
bind to proteins and lead to an immune response (Warrington, 2012). 
 
Another drug molecule that appears to link reactive metabolite formation and the prohapten 
hypothesis is halothane. Halothane is oxidized by hepatic cytochrome P450 to the reactive 
trifluoroacetyl chloride, which can cause hepatotoxicity (Njoku et al., 1997). Although the 
incidence of liver failure is low, most patients who develop halothane-induced 
hepatotoxicity have antibodies against trifluoroacetyl-modified proteins (Vergani et al., 
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1980) and this implies that modification of protein by the reactive metabolite has led to an 
immune response. 
 
It is important to determine which proteins are modified and to identify the reactive 
metabolites causing these modifications. Although radiochemical methods can be used, it is 
more common to use immunochemical methods to determine, which proteins are modified. 
This involves synthesis of an immunogen (such as reactive metabolite adduct conjugated to 
protein), against which antibodies are raised via immunization of animals with the 
immunogen (Attia, 2010). The identification of the modified proteins as well as reactive 
metabolites that are implicated is essential for a better understanding of idiosyncratic drug 
reactions. 
 
1.3.2 Danger Hypothesis 
The danger hypothesis was first proposed by Matzinger in 1994 in response to 
discrepancies in the field of immunology as to what initiates and how an immune response 
is initiated (Matzinger, 1994). In this study, it was reported that the immunologists 
viewpoint that the immune system’s primary goal is to discriminate between self and non-
self, may be changed. He presented the possibility that the immune system does not care 
about self and non-self; The primary driving force for this hypothesis being the need to 
detect and protect against danger (Matziger, 1994). The difference between the self and 
non-self in the danger hypothesis is that the major stimulus for initiation of an immune 
response comes from endogenous rather than exogenous signals and is controlled, not by 
cells of the immune system, but rather by the damaged tissue itself (Matziger, 2001). 
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The danger hypothesis affected the way immunologists view the immune response. In the 
danger hypothesis, a reactive metabolite causes cell damage or cell stress, which leads to 
upregulation of co-stimulatory factors on antigen presenting cells. Thus, the major 
determinant of whether an immune response is mounted against some agent is determined 
by whether that agent causes some type of cell damage. Assuming that most IDRs are 
immune-mediated, the danger hypothesis has the potential to explain whether drug (or more 
likely its reactive metabolites) causes cell damage (Li and Uetrecht, 2010). Damaged cells 
release danger signals, such as pro-inflammatory cytokines, TNF-α and 1L-1β. These 
signals can trigger an immune response, which leads to hypersensitivity as an adverse side 
effect (Figure 2). 
 
 
Figure 2: Hypersensitivity by the immune system 
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1.4 Nevirapine and Nevirapine Alkyne 
Treatment of HIV-1 infections with nevirapine is associated with skin and liver toxicity. 
These two organ toxicities range from mild to severe, in rare cases resulting in life-
threatening liver failure or toxic epidermal necrolysis (Popovic et al., 2010). Nevirapine is 
one antiretroviral drug associated with IDRs. Figure 3 shows the structure of the 
Nevirapine. In this study we focused on studying Nevirapine induced hypersensitivity. The 
most common adverse effect of nevirapine is the development of mild or moderate rash 
(13%). Severe or life-threatening skin reactions have been observed in 1.5% of patients, 
including Stevens–Johnson syndrome which is a painful red or purplish rash that spreads on 
skins and mucous membranes, toxic epidermal necrolysis and hypersensitivity syndrome. 
 
 
Figure 3: Structures of Nevirapine (NVP) 
 
Nevirapine it is a non-nucleoside reverse transcriptase inhibitor used for the treatment of 
HIV infections. The use of Nevirapine is limited by a relatively high incidence of skin rash, 
some of which are life threatening and idiosyncratic drug-induced liver injury (IDILI). It 
also causes a rash in female Brown Norway rats (Shenton et al., 2003; 2004). The rash is 
clearly immune mediated in rats, and the characteristics of the rash in the rat model are very 
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similar to those in humans; therefore, it is likely that the mechanisms involved in the 
process are also similar (Shenton et al., 2005). 
 
Drug metabolism plays an important role in developing IDR. Most drug metabolism occurs 
in the liver. However, liver-generated metabolites are unlikely to stimulate T-cell-mediated 
reactions in other organs, unless the metabolite avoids detoxification processes, and is 
stable enough to circulate in the blood (Ju and Uetrecht, 1999; Winter et al., 2004). 
Although the liver is the main site of drug metabolism, it is known that other organs 
express drug-metabolizing enzymes, such as the skin or immune cells themselves 
(Lavergne et al., 2008). 
 
Chen et al. (2008) observed that substitution of the NVP methyl hydrogens with deuterium 
markedly decreased the formation of 12-OH-NVP as well as the incidence and severity of 
the rash.  The treatment with a lower dose of 12-OH-NVP induced the same degree of skin 
rash as the treatment with NVP itself (see Figure 4). In addition, Sharma et al. (2013), using 
Brown Norway (BN) rat model, showed that the 12-hydroxylation pathway is involved in 
the induction of the skin rash and the most likely candidate for a reactive metabolite of 12-
OH-NVP is the benzylic sulfate. Sharma et al. (2013) reported that Nevirapine is 
metabolized in the liver by cytochrome P450 (CYP) to Nevirapine metabolites, which 
induces the skin rash. They proposed the chemical mechanism of NVP-induced skin rash as 
a result from the covalent binding of 12-OH-NVP sulfate in the skin as shown in Figure 4. 
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Figure 4: Chemical mechanism of NVP-induced skin rash (Sharma et al., 2013) 
 
Lavergne et al. (2008) stated that skin cells express less drug metabolizing enzymes than 
hepatocytes; however, skin is larger in terms of weight and surface area than the liver, and 
is also highly vascularized. Therefore, the skin could be as important as the liver in 
bioactivating certain drugs, and could play a specific key role in drug-induced skin 
reactions. 
 
The ability of some metabolites, or sometimes the parent drug itself, to form protein 
adducts has been mainly investigated in vitro. In drug-induced immune-mediated liver 
diseases, such drug-protein adduct formation has been correlated with the development of 
hepatic injury (Aithal and Day, 2007). The formation of a metabolite-protein adducts could 
be cytotoxic by altering an important protein function. 
 
Through the research activities in the Department of Pharmacology at the Faculty of 
Medicine and Health Sciences in University of Sherbrooke, Prof. Klaus Klarskov and his 
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research team designed a Nevirapine (NVP) analog in which the cyclopropyl group was 
replaced with an alkyne group.  This compound (referred to as 1 Nevirapine alkyne) was 
synthesized following a seven-step sequence suitable for large scale production (Bernard et 
al., 2009). Figure 5 shows the structures of 1 Nevirapine alkyne in comparison with the 
Nevirapine. The terminal alkyne group is an appropriate site for reaction with azide 
conjugated probes using click chemistry adapted to biological media, as illustrated in 
Figure 6, to facilitate the detection of the modified protein by Nevirapine metabolite 
(Bernard et al., 2009). 
        
 
Figure 5: Structures of Nevirapine and Nevirapine alkyne (Bernard et al., 2009) 
 
 
Figure 6: Click fishing principle of metabolites of 1 Nevirapine alkyne (Bernard et al., 
2009) 
Nevirapine alkyne (NVP-ALK) Nevirapine (NVP) 
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1.5 Animal Model  
If we could predict and prevent IDRs it would have a profound effect on drug development 
and therapy. Given their unpredictable nature, IDRs are generally not detected until the 
drug is released onto the market because clinical trials involve a limited number of subjects 
(Attia, 2010). Hypothesis testing requires valid animal models with characteristics similar 
to the idiosyncratic reactions that occur in patients. The best models, in which a rodent 
develops a clinical syndrome similar to what occurs in humans, appear to be penicillamine-
induced autoimmunity in Brown Norway (BN) rats and nevirapine-induced skin rash in rats 
(Shenton et al., 2003). The nevirapine-induced skin rash in rats has characteristics very 
similar to the idiosyncratic reaction that occurs in humans. It is therefore perfectly suited 
for studying drug-induced idiosyncratic skin reactions. 
 
1.6 Click Chemistry 
The “Click Chemistry” was introduced in 2001 (Kolb et al., 2001) to describe pairs of 
functional groups that rapidly and selectively react “click” with each other in mild, aqueous 
conditions. The concept of Click Chemistry has been transformed into convenient, versatile 
and reliable two-step coupling procedures of two molecules (Kolb et al., 2001). A click 
reaction must be of wide scope, giving consistently high yields with a variety of starting 
materials. It must be easy to perform, be insensitive to oxygen or water, and use only 
readily available reagents. Reaction work-up and product isolation must be simple, without 
requiring chromatographic purification (Kolb et al., 2001). The presence of water in these 
reactions is beneficial, not just for reactivity reasons, but also because water is the best heat 
capacity handling the enormous heat output when click reactions are performed (Kolb and 
Sharpless, 2003).   
Chapter 1: Introduction 
15 
Most common click chemistry reactions (Figure 7) are: 
1. Cu(I)-catalyzed Azide-Alkyne Click Chemistry reaction (CuAAC)  
2. Strain-promoted Azide-Alkyne Click Chemistry reaction (SPAAC)  
3. Tetrazine-Alkene Ligation  
 
 
Figure 7: Overview of the most common Click Chemistry reactions (Jena Bioscience, 
2016) 
The Cu(I)-catalyzed Azide-Alkyne Click Chemistry reaction (CuAAC) (1) relies on the 
presence of Cu(I) ions whereas the Copper-free strain-promoted Azide-Alkyne Click 
Chemistry reaction (SPAAC) (2) and Tetrazine-Alkene Ligation (3) efficiently proceed 
without metal catalysis. The well-known Copper-free Azide-Phosphine reaction 
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(Staudinger Ligation) is hampered by the instability of phosphines and slow reaction 
kinetics. Recent focus therefore shifted towards strain-promoted reactions with 
cyclooctynes and Tetrazine-Alkene Ligation, respectively (Jena Bioscience, 2016). 
 
The copper-(I)-catalyzed 1,2,3-triazole formation from azides and terminal acetylenes is a 
particularly powerful linking reaction, due to its high specificity, and the bio-compatibility 
of the reactants. Pasini (2013) reported that Cu(I)-catalyzed Azide-Alkyne cycloaddition 
(CuAAC) is an established tool used for the construction of complex molecular 
architectures and given its efficiency, it has been widely applied for bioconjugation, 
polymer and dendrimer synthesis. Figure 8 shows the ‘perfect’ reaction as defined by Kolb 
and Sharpless (2003), which was made possible because of the dramatic rate acceleration of 
the Azide-Alkyne coupling event under copper-(I) catalysis (Rostovtsev et al., 2002; 
Tornøe et al., 2002), and the beneficial effects of water (Rostovtsev et al., 2002).  
 
 
Figure 8: The premier click chemistry reaction (Kolb and Sharpless, 2003) 
The copper-(I)-catalyzed coupling of azides and terminal acetylenes creates 1,4-
disubstituted 1,2,3-triazole linkages, which share useful topological and electronic features 
with nature’s ubiquitous amide connectors. However, unlike amides, triazoles are not 
susceptible to cleavage (Kolb and Sharpless, 2003). 
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1.7 Mass Spectrometry  
Mass spectrometry (MS) is an analytical technique that can be used selectively to detect 
and determine the amount of a given analyte. Accurate mass MS is also used to determine 
the elemental composition and the molecular structure of an analyte (Watson and 
Sparkman, 2007). It can provide both qualitative (structure) and quantitative (molecular 
mass or concentration) information on molecules after their conversion to ions and it can be 
used to identify unknown molecules and proteins (Ho et al., 2003). 
 
Electrospray ionisation mass spectrometry (ESI-MS) has been used in laboratories to 
provide a sensitive, robust, and reliable tool for studying, at femto-mole quantities in 
micro-litre sample volumes, non-volatile and thermally labile bio-molecules that are not 
amenable to analysis by other conventional techniques (Ho et al., 2003). Figure 9 shows a 
conceptual illustration of the mass spectrometer as provided by Watson, and Sparkman 
(2007). This conceptual illustration shows the major components of the mass spectrometer, 
which are: (i) sample inlets (dependent on sample and ionization technique); (ii) ion source 
(origin of gas phase ions); (iii) mass-to-charge ratio (m/z) analyzer (portion of instrument 
responsible for separation of ions according to their individual m/z values); (iv) detector 
(generates the signals that are a recording of the m/z values and abundances of the ions); (v) 
vacuum system (the components that remove molecules, thereby providing a collision-free 
path for the ions from the ion source to the detector); and (vi) the computer (coordinates the 
functions of the individual components and records and stores the data). 
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Figure 9: Conceptual illustration of the mass spectrometer showing the major components 
of mass spectrometer (Watson and Sparkman, 2007). 
 
1.7.1 Uses of mass spectrometry 
Mass spectrometry has become established as the primary method for protein identification 
from complex mixtures of biological origin. Almost without exception, protein 
identification is based on the analysis of peptides generated by proteolyic digestion. The 
most widely used enzyme is trypsin, which hydrolyzes the protein on the C-terminal side of 
lysine and arginine, unless the subsequent amino acid in the sequence is a proline (Baldwin, 
2004).  
 
The mass spectrometry (MS) may also be used for: (i) mass determination of biomolecules; 
(ii) identifying unknown compounds; and (iii) sequencing determination.  
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1.8 Protein Identification 
Mass spectrometry (MS)-based proteomics is a highly sensitive method for protein 
identification and characterization (Aebersold and Mann, 2003) and it is a standard 
platform in proteomics (Delahunty and Yates III, 2005). The two commonly used MS-
based proteomic approaches are multidimensional protein identification technology 
(MudPIT) and shotgun proteomics where peptides from in-solution digestion of the whole 
proteome are usually analyzed by multidimensional LC-MS/MS. The gel-based proteomics 
where peptides eluted from one-dimensional or two-dimensional gel electrophoresis (1DGE 
or 2DGE) (Görg et al., 2004) are normally analyzed by MALDI-MS or LC-MS/MS. The 
main difference between ESI and MALDI for protein identification is the ease of 
fragmentation of peptides. ESI normally produces multiply charged parent ions that require 
less energy for fragmentation compared to singly charged peptides, which are the dominant 
in MALDI (Ishihama, 2005). 
 
1.9 Protein S-Glutathionylation 
Glutathione (GSH) is an antioxidant in cells that prevents cell damages caused by reactive 
oxygen species such as free radicals reactive nitrogen species, peroxides, lipid peroxides 
and heavy metals. 
 
Protein S-glutathionylation is a reversible mechanism for the global regulation of protein 
functions. It occurs through the formation of mixed disulfides between GSH and cysteine in 
proteins. In oxidative stress, glutathione is converted to its oxidized form, glutathione 
disulfide (GSSG). It has long been known that S-glutathionylation occurs after oxidative 
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stress (Brigelius et al., 1983). The S-glutathionylation significantly affects the protein 
structure and function (Holmgren et al., 2005; Dalle-Donne et al., 2007). 
 
In several cell types, Reactive Oxygen Species (ROS) production catalyze glutathionylation 
of free thiol groups (-SH) on cysteine residues of proteins to form protein-glutathione 
mixed disufide adducts (Pr-SSG) (Hurd et al., 2005; Leichert and Jakob, 2006; Gallogly 
and Mieyal, 2007; Janssen-Heininger et al., 2008). Protein S-glutathionylation can affect 
the function of various proteins including actin, protein tyrosine kinases and phosphatases, 
Ras, and transcription factors such as NF-kB, and hence modulate cell signaling and 
function (Sakai et al., 2012).  
 
The objective of using GSH antibody is to identify specific proteins that are modified by 
glutathionylation. It has been noted that the reactivity of the antibody depends upon the 
nature surrounding the epitope and that some glutathionylated proteins are not recognized 
or only weakly recognized by the antibody (Brennan et al., 2006). Nevertheless, the 
antibody technique allows detection of glutathionylated proteins in cells and tissues under 
conditions of oxidative or nitrosative stress (Hill et al., 2010). 
  
1.10 Hypothesis and Objectives 
Our hypothesis is that idiosyncratic skin reaction associated with NVP treatment are due to 
post-translational modifications of proteins (e.g., glutathionylation) detectable by MS. The 
specific objectives derived from the general objective were as follow: 
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1. To implement the click chemistry approach to detect proteins modified by a reactive 
NVP-Alkyne (NVP-ALK) metabolite. The purpose of using NVP-ALK was to couple 
it with Biotin using cycloaddition Click Chemistry reaction. 
2. To detect protein modification using Western blotting and Mass Spectrometry 
techniques, which is important to understand the mechanism of NVP induced 
toxicity. 
3. To identify the proteins using MASCOT search engine for protein identification, by 
comparing obtained spectrum from Mass Spectrometry with theoretical spectrum to 
find a matching peptide sequence. 
4. To test if the drug or drug metabolites can cause harmful effects, as the induction of 
oxidative stress in cells (via protein glutathionylation). Oxidative stress causes cell 
damage that mediates signals, which likely induces the immune response. 
  
Chapter 2: Materials and Methods 
 
22 
CHAPTER 2 
MATERIALS AND METHODS 
 
 
2.1 Optimizing Click Reaction Conditions 
The protocol that has been used in this work was introduced by Presolski et al. (2011) 
where ascorbate was used as reducing agent to maintain the required cuprous oxidation 
state. Three to five equivalents of copper-binding ligand TBTA was used to accelerate the 
reaction and serve as a sacrificial reductant, which protects the biomolecules from 
oxidation. 
 
The following steps summarize a complete test that has been conducted for NVP-ALK 
click chemistry reaction. In an Eppendorf tube, 4 µl of 5 mM Biotin-PEG3-Azide in 
Dimethyl sulfoxide (DMSO) (Sigma) was added to 4 µl of 5 mM NVP-ALK in DMSO 
(Synthetized in Prof. Klaus Klarskov laboratory), then 4 µl of 50 mM CuSO4 in H2O 
(Sigma) was pipetted to 4 µl of 50 mM ascorbic acid in H2O (Sigma). After that, 11.7 µl of 
1 mM TBTA in DMSO (Sigma) and 168 µl of Phosphate-buffered saline (PBS) 1X were 
added. Thereafter, the mix was vortex and incubated at different temperatures for variable 
incubation periods. After completing the incubation, the analysis of samples was carried 
out by ESI–MS and tandem MS on a Micromass Q-TOF-2 (Waters Corp. ON, Canada) to 
verify if click reaction happened through detecting the mass of conjugated molecule.  
 
Several assays were attempted to determine the optimized conditions for the click reaction, 
such as changing the temperature (room temperature to 95
o
C), incubation period (2 hr to 24 
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hr), concentrations of both molecules (NVP-ALK and Biotin-PEG3-azide), the use of 
ligand (with and without). Among these trials, the optimized conditions were obtained 
when both NVP-ALK and Biotin-PEG3-Azide molecules were conjugated together. This 
was achieved at 37
o
C for an incubation period of 24 hr with a TBTA ligand. The optimized 
conditions are listed in Table 1. 
 
Table 1: Optimized Conditions for Click Chemistry Reaction  
Temperature 37
o
C 
Incubation period 24 hr 
Ligand TBTA* 
 *TBTA =Tris-(benzyltriazolylmethyl) amine  
 
2.2 Confirmation of Click Reaction using Erlotinib  
This step was used to verify and confirm the occurrence of the click chemistry reaction. 
Erlotinib (a drug used for cancer treatment) was used as it has already an alkyne group in 
its structure. The ChemDraw software was used to draw the conjugated molecule of Biotin-
PEG3-Azide and Erlotinib (see Figure 15). Thereafter the same procedure used for NVP-
ALK was followed: In an Eppendorf tube 4 µl of 5 mM biotin-PEG3-Azide in DMSO was 
added to 4 µl of 5 mM Erlotinib in DMSO, and then 4 µl of 50 mM CuSO4 in H2O was 
pipetted to 4 µl of 50 mM ascorbic acid in H2O. After that, 11.7 µl of 1 mM TBTA in 
DMSO and 168 µl of PBS 1X were added. Thereafter, the mix was vortex and incubated at 
37
o
C for 24 hr. After completing the incubation, the analysis of samples was carried out by 
ESI–MS and tandem MS on a Micromass Q-TOF-2 (Waters Corp. ON, Canada) to verify if 
click reaction happened through detecting the mass of conjugated molecule. 
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2.3 Animal Care 
Animal model was developed and characterized by Daniel Defoy in Prof. Klaus Klarskov 
laboratory. This animal model of Nevirapine-Alkyne induced skin rash in female Brown 
Norway (BN) shares many characteristics of the rash that occurs in human. The rats were 
given Nevirapine-Alkyne for 6 weeks until they developed rashes. In addition, some rats 
were given Nevirapine and some others were not treated and were, therefore, used as 
controls in this study. Female BN rats (150−175 g; between 8 and 10 weeks of age) were 
obtained from Charles River (Montreal, QC). 
 
Rats were housed in pairs in standard cages in a 12:12 hr light/dark cycles with access to 
water and powdered lab chow diet (Leis Pet Distribution, Inc. Wellesley, ON). Following a 
1-week acclimatization period, rats were either maintained on control chow or started on 
drug-containing diet (treatment groups). Drug was mixed thoroughly with powdered lab 
chow; it was to be administered orally. The amount of drug administered to animals was 
150 mg/kg/day calculated based on body weight of the rats and their daily food intake. Rats 
were exposed to Nevirapine and Nevirapine-Alkyne for another 3 weeks until they 
developed skin rash as an adverse effect.  
 
2.4 Protein Extraction 
Rats were sacrificed by Daniel Defoy via CO2 asphyxiation. At sacrifice, hair was removed 
from the rats using an electric shaver, and the skin was cleaned of remaining hair using 
PBS (1× phosphate buffered saline, pH 7.4) and Kimwipes. Whole skin from the back was 
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removed homogenized in cell lysis buffer (Cell Signaling Technologies) with protease 
inhibitor (SIGMA) in a 10:1 ratio using a Polytron 2100 homogenizer (1.5 mL working cell 
lysis buffer per fraction). In order to clarify the crude fractions, samples were centrifuged at 
13,000 rpm for 2 min. The supernatant was separated from insoluble debris and stored at 
−80 °C. 
 
2.5 Protein Quantification 
After protein extraction from treated and untreated rats, bicinchoninic acid (BCA) protein 
assay kit (Thermofisher) was used to determine protein concentration in each sample. BCA 
kit contains BSA (bovine serum albumin) and two reagents A and B. The BSA was diluted 
using distilled water; the dilutions were 2 mg/ml, 1.5mg/ml, 0.75 mg/ml, 0.5 mg/ml, 0.25 
mg/ml, 0.125 mg/ml, and 0.025 mg/ml of BSA. Reagents A and B were combined together 
in 50/1 ratio just before protein quantification.  Then, 25 µl of each BSA standard dilution 
and from the samples were pipetted into 96 microplate. After that, 200 µl of the mixture 
(reagents A and B) was added to each sample and standard. Thereafter, the plate was 
incubated at 37°C for 30 min. The absorbance was measured at 562 nm on a plate reader. 
Finally, we used the Excel software (Microsoft Inc.) to calculate the protein concentration. 
 
2.6 Western Blot  
Protein extracted from the untreated rats as control (CLT) was used. Thereafter the 
following procedure was followed: 
In an Eppendorf tube, 22 µg of the supernatant from homogenized whole rat skin treated 
with NVP-ALK was added to click chemistry reaction mixture, which contained 4 µl of 5 
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mM biotin-PEG3-Azide in DMSO, and 4 µl of 50 mM CuSO4 in H2O. After that, 4 µl of 50 
mM ascorbic acid in H2O was added to 11.7 µl of 1 mM TBTA in DMSO and 168 µl of 
PBS 1X. Thereafter, the mix was vortex and sonicated for 15 min, and incubated at 37
o
C 
for 24 hr. This process was repeated for the control (CTL) samples. 
 
Electrophoreses: 
After 24 hr of incubation at 37
o
C, the following procedure was used to separate and to 
visualize proteins on a western blot:  
Twenty µl of each sample was mixed with 10 µl 2X sample loading buffer (62.5 mM Tris-
HCl, pH 6.8 (Sigma-Aldrich), 2% SDS (Sodium dodecyl sulfate), 25% glycerol, 0.01% 
bromophenol blue) with freshly prepared 5% Dithiothreitol (DTT) (Promega) were heated 
at 95
o
C for 5 min. After that, the samples were loaded on the gel (Precast gel, 4–20% 
Criterion Tris-HCl Gel, 18 well, 30 µl) (BIO-RAD). Then Electrophoresis was run at 20 
mA then increased to 40 mA, after passing the stacking gel. The electrophoresis running 
buffer (Bio-Rad) consisted of 25 mM Tris, 192 mM glycine, and 0.1% SDS, pH 8.3. The 
electrophoresis was performed using PowerPac 1000 (BIO-RAD). After electrophoresis, 
the proteins were visualized using coomassie blue stain (BIO-RAD). 
 
Transfer: 
Protein was transferred onto a Polyvinylidene difluoride (PVDF)–membrane (Western 
blotting membrane) (Roche) as it has more affinity and binding capacity to protein than 
nitrocellulose membrane. Before protein transfer, the PVDF membrane was soaked in pure 
methanol. The transfer was performed using a Trans-Blot SD semi-dry transfer cell (BIO-
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RAD) for 55 min. at 0.8 mA/cm
2
 as described by Methogo et al. (2005). A thick filter paper 
was soaked in transfer buffer (20% Tris–glycine running buffer). 
 
After semi dry transfer, the membrane was stained with India ink (100 ml H2O + 1 ml 
acetic acid + 100 µl of India ink + 50 µl TWEEN 20) for 24 hr. Then, washed twice with 
Tris-buffered saline Tween-20 (TBST) solution for 5 min. Membrane was then blocked in 
5% non-fat milk blocking solution in TBST (5 g milk + 100 ml TBST) for 2 hr at room 
temperature. Then, it was washed in three changes of TBST. 
 
Following that, the membrane was incubated with a 1:5000 dilution of Streptavidin HRP 
(Invitrogen) (50 ml TBS + 50 µl Tween 20 +10 µl streptavidin HRP) overnight. Thereafter, 
the membrane was washed 3 times for 20 min. with TBST, then incubated with enhanced 
chemiluminescence ECL (western lightening-ECL) (PerkinElmer) (1 ml reactive A + 1 ml 
reactive B, mix) for 1 min. The film was exposed in a dark room for 30 sec, 1 min., and 5 
min. 
 
2.7 In Gel Digestion 
After detecting protein bands by Western blotting, another electrophoresis was performed 
as described previously (Section 2.7). Then the gel was fixed in 40% methanol / 10% acetic 
acid / 50% water for 30 min. After that, the gel was stained with coomassie blue stain 
(BIO-RAD) overnight, then destained by using distilled water until background became 
clear. The gel was placed over a glass tray then bands of interest were cut as shown in 
Figure 10. 
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 Figure 10: A photo showing the stained gel and the cut bands 
 
After cutting the bands of interest (as shown in Figure 10), the gel pieces (protein bands) 
was placed in Eppendorf tube and a shortly prepared 400 µl of 100 mM NH4HCO3 was 
added then vortexed then left for 15 min. After that, solution was removed from the tube 
and 400 µl of acetonitrile (ACN) was added. After 15 min., ACN was removed from the 
tube then 50 µl of shortly prepared DTT 5 mg/ml in 200 mM NH4HCO3 was added then 
incubated at 37
o
C for 45 min. then the DTT solution was removed after the incubation. 
After that, 70 µl of Iodoacitamide 25 mg/ml in 200 mM NH4HCO3 shortly prepared was 
added, then incubated at room temperature for 30 min. in the dark. Iodoacetamide solution 
was removed. 400 µl of solution 100 mM NH4HCO3 containing 50% ACN was added and 
incubated at room temperature for 30 min. on the mixer. Solution was removed then gel 
pieces were smashed (by using a clean tip) then dried using a vacuum dryer for 2-5 min. 
The Gel pieces were rehydrated and digested on ice with 25 µl of 100 ng/µl trypsin 
(Trypsin/Lys-C Mix, Mass Spec Grade, Promega) in 40 % Dimethylformamide (DMF) 
/100 mM NH4HCO3 for 15 min. Then excess solution was removed then 50 µl 50 mM 
Chapter 2: Materials and Methods 
 
29 
NH4HCO3 20% DMF were added and incubated at 37
o
C overnight. Samples were 
centrifuged and incubated in an ultrasonic bath for 10 min., followed by another 
centrifugation. Finally, 5 µl of 10% formic acid HCOOH solution in water was added, 
sample was placed in ultrasonic bath for 15 min. then centrifuged again.  Supernatant was 
collected, then placed in a clean Eppendorf (see Figure 11). 
 
Pre-LC-MS-MS sample preparation: 
Before running the analysis, 1 µl of 5M urea in water was added to each sample. After that, 
the sample was dried using a speed-vac. 
 
 
Figure 11: Basics of protein identification at the MS level 
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2.8 Analysis by LC-ESI-MS and Protein Identification: 
The method used for the analysis by LC-ESI-MS for protein identification was adapted 
from the work conducted by Prof. Klaus Klarskov (Dept. of Pharmacology and Physiology, 
University of Sherbrooke) detailed in Methogo et al. (2007). Peptides derived from 
digestion were analyzed by nanoliquid chromatography coupled on-line with tandem 
electrospray ionization time-of-flight mass spectrometry (nLC-ESIMS/MS) consisting of a 
capillary liquid chromatograph with autosampler and a QTOF 2E mass spectrometer 
(Waters, MA, USA) (Figure 12). Tryptic peptides were dissolved in 14 µl solvent A (1% 
acetonitrile, 1% isopropanol in 0.2% aqueous formic acid), loaded onto a 0.5 mm × 250 µm 
i.d. union packed with Magic C18 AQ (200 A, 5 µm; Michrom BioResources,Auburn, CA) 
and separated on a 100 µm i.d. × 10 cm capillary column packed with the same material. 
Each analysis was succeeded by injection of 10 µl 50% (v/v) aqueous isopropanol followed 
by running a blank gradient, which efficiently eliminated contamination from sample carry 
over.  
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Figure 12: A photo showing the Q-TOF-2 mass spectrometer used in LCMS analysis 
 
The following linear gradient was used: from 10 to 70% B in 30 min., to 90% B in 5 min., 
and 10% B in 3 min. The flow rate was split approximately 10× to 0.25–0.30 µl/min. 
Survey scans were acquired at 1.9 s/scan. Depending on the charge state and intensity, 
doubly and triply charged parent ions were automatically selected for tandem mass 
spectrometry acquired at 1 s/scan with a preset maximum of five scans per selected parent 
ion. Since singly charged parent ions were not selected for tandem mass spectrometry, the 
intensity threshold could be lowered to a minimum eliminating the risk of spending 
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acquisition time on ions from background, impurities and detergents. Although a low 
threshold is not a guaranty of acquiring MS/MS spectra useful for protein identification, it 
ensures selection of maximum number of doubly and triply charged ions for MS/MS 
analysis, during the separation. Raw MS/MS spectra were processed automatically using 
the ProteinLynx software and converted into peak lists readable by the MASCOT search 
algorithm (http://www.matrixscience.com). The following search parameters were used: 
database; MSDB, species; Rattus, allowance of two missed tryptic cleavages, oxidation of 
methionine and cysteine carbamidomethylation, fragment mass tolerance; 0.25 Da. 
  
2.9 Protein S-glutathionylation  
To test this hypothesis, we extracted proteins from rats treated or not with NVP and NVP-
ALK. Twenty microliters of each sample was added to 10 µl of sample loading buffer (62.5 
mM Tris-HCl, pH 6.8, 2% SDS, 25% glycerol, 0.01% bromophenol blue) without DTT, 
and then heated at 95
o
C for 5 min. Then samples were loaded on the gel (4–20% 
Criterion Tris-HCl Gel, 18 well, 30 µl) (BIO-RAD). Electrophoresis were run at 20 mA 
then increased to 40 mA after passing the stacking gel (PowerPac 1000, BIO-RAD). 
Electrophoresis running buffer (BIO-RAD) consisted of 25 mM Tris, 192 mM glycine, and 
0.1% SDS, pH 8.3. 
 
Transfer: 
After electrophoresis, the proteins were transferred onto a pre-soaked PVDF–membrane 
(Western blotting membrane) (Roche) in pure methanol for 15-30 min. The membrane 
wetting is an important step for proper protein binding. After electrophoresis, the gel was 
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immediately equilibrated in transfer buffer (2.93g glycine 200 ml methanol, up to 1 liter 
w/dH20) for 15 min. This step was conducted to remove the excess electrophoresis buffer 
and detergent from SDS-gel. The wetted blot paper was also soaked and the buffer and gel 
were placed between wetted blot papers. The cathode plate was placed carefully onto the 
stack. The transfer was performed using a Trans-Blot SD semi-dry transfer cell (BIO-RAD) 
for 55 min. at 0.8 mA/cm
2
. 
 
After that, the membrane was stained with India ink (100 ml H2O + 1 ml acetic acid + 100 
µl of India ink + 50 µl TWEEN 20) for 24 hr. Then, it was washed with TBST. Membrane 
was then blocked in 5% non-fat milk blocking solution in TBST (5 g milk +100 ml TBST) 
for 2 hr. at room temperature then washed twice with TBST for 5 min. each.  
 
The membrane was incubated overnight at room temperature with the first antibody anti-
glutathione monoclonal antibody (Virogen) diluted 1000x in TBST. Then membrane was 
washed (three changes) in TBST followed by a 90 min. incubation at room temperature in 
secondary antiserum Goat Anti-Mouse IgG H&L (HRP) diluted at 1: 10000 (5 µl antibody 
+ 50 ml TBS). Then membrane was washed twice with TBST 
 
After that, it was incubated with enhanced chemiluminescence ECL (western lightening-
ECL) (PerkinElmer) (1 ml reactive A + 1 ml reactive B, mix) for 1 min. Films exposed in a 
dark room for 30 sec, 1 min., 5 min. 
 
 
Chapter 2: Materials and Methods 
 
34 
On membrane digestion: 
For identification of glutathionylated proteins, detected protein bands were cut directly 
from the PVDF membrane and digested on the membrane as described by Methogo et al. 
(2005). Figure 13 summarizes the membrane digestion while Figure 14 shows the PVDF 
membrane after cutting bands of interest. 
 
 
 
Figure 13: On-membrane tryptic digestion of proteins for mass spectrometry analysis 
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Figure 14: PVDF membrane after cutting bands of interest 
 
 
Proteolytic cleavage, sample preparation. 
After electro-blotting and immuno detection, protein spots for on-membrane digestion, 
were excised washed in 1 ml 20% methanol MeOH and reduced in 20 µl of 100 mM 
NH4HCO3 containing 5 g/l DTT for 45 min. at 37°C. 
 
The carbamidomethylation was performed in the dark in 40 l of 200 mM NH4HCO3 
containing 25 µg/µl of iodoacetamide for 30 min. Membrane pieces were rinsed four times 
in 400 l 100 mM ammonium bicarbonate containing 50% acetonitrile. 
 
Digestion on the membrane was performed at 37°C for 3.5 hr in 8 µl of 50% DMF, 100 
mM NH4HCO3 containing 20 ng/µl of trypsin. This buffer (NH4CO3/DMF) was prepared 
freshly prior to the digestion and DMF was treated with Molecular Sieves (8-12 Mesh 
beads, 4A) prior to use. 
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The samples were centrifuged every 30 min. to prevent the membrane pieces from drying 
out. After digestion, 1 µl 5 M urea was added to the samples. The samples were sonicated 
for 2 min. and, followed by immediate transfer to Q-TOF vials then lyophilization. For 
analysis and protein identification, samples were sent to Phenoswitch bioscience 
(Sherbrooke). 
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CHAPTER 3 
RESULTS  
 
3.1 Click Chemistry Reaction 
First step of the project was to perform a click chemistry reaction by coupling two 
molecules, which are Nevirapine Alkyne (NVP-ALK) and Biotine-PEG3-Azide using 
certain conditions. The NVP-ALK and Biotine-PEG3-Azide conjugated molecule is shown 
in Figure 15. Click chemistry reaction was the tool to detect proteins modified by reactive 
metabolites of the NVP-alkyne in the samples. 
 
To determine if the click reaction occurred, the mass of each molecule and the mass of the 
conjugated molecule was calculated using the ChemDraw software and was measured by 
mass spectrometry (MS). The MS analysis of the samples revealed that NVP-ALK and 
Biotin conjugate are binding together under these circumstances (optimized conditions 
listed in Table 1) and a new molecule has a mass equal to the sum of the individual masses 
of NVP-ALK and Biotin conjugate (see result for ESI-MS analysis result). It should be 
mentioned that the Tris-(benzyltriazolylmethyl) amine (TBTA) was used to protect Cu(I) 
from oxidation. 
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Figure 15: Nevirapine-Alkyne and Biotin-PEG3-Azide click reaction and expected m/z for 
the conjugated product 
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3.2 Confirmation of Click Chemistry Reaction Conditions using Erlotinib  
This step was used to verify and confirm the occurrence of the click chemistry conditions. 
Erlotinib was used as it has an alkyne group in its structure. The ChemDraw software was 
used to draw the conjugated molecule of Biotin-PEG3-Azide and Erlotinib. Figure 16 
shows the individual molecules and the conjugated one as calculated by ChemDraw 
software. 
 
 
Figure 16: Confirmation of click chemistry reaction conditions using Erlotinib molecule 
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3.3 Detection of Click Chemistry Reactions using Mass Spectrometry 
The click chemistry reactions were conducted using the optimized working conditions, 
which were determined as detailed in Chapter 2 and the optimized conditions are listed in 
Table 1.  
 
The structure and the molecular weight of Biotin-PEG3-Azide are shown in Figures 15 and 
Figure 16. As mentioned earlier, the drawings of the individual molecules before starting 
the click chemistry reaction was important to analyze each molecule to confirm their mass 
and to test the accuracy of the MS instrument. 
 
Figure 17 shows ESI/MS/MS Spectrum of Biotin-PEG3-Azide, the mass on charge (m/z) 
was identical to calculated mass by ChemDraw software.  
 
 
Figure 17: ESI-MS/MS Spectrum of Biotin-PEG3-Azide 
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In addition, Figure 18 shows the ESI/MS/MS analysis for Nevirapine-Alkyne molecule 
before click chemistry reaction. 
 
 
Figure 18: ESI-MS/MS spectrum of Nevirapine–Alkyne 
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Figure 19 shows the ESI-MS of a mixture contained both molecules (Nevirapine-Alkyne + 
Biotin-PEG3-Azide) separately in the presence of copper sulfate as catalyst and ascorbic 
acid.  The two molecules were detected separately, which means that cycloaddition reaction 
did not occur. Despite the fact that click chemistry reaction is a high yield reaction, it 
needed a lot of optimisation to determine the best condition in order to allow the 
cycloaddition reaction to occur. During the optimization, different experimental conditions 
such as varying the temperature (room temperature to 95
o
C), the time of incubation (2 hr to 
24 hr), the concentrations of both molecules (NVP-ALK and Biotin-PEG3-azide) and 
employing or not TBTA (Cu(I)-stabilizing ligand) were tested. Figures 20 and 21 show 
some experimental conditions that were not successful. The optimized conditions were 
obtained when both NVP-ALK and Biotin-PEG3-Azide molecules were conjugated 
together. This was achieved at 37
o
C for an incubation period of 24 hr with a TBTA Cu(I)-
stabilizing ligand (Table 1). 
 
Figure 19: ESI-MS after click chemistry reaction. 
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Figure 20 was obtained after ESI/MS analysis of click chemistry reaction without using 
TBTA as ligand. The figure shows that the reaction did not yield the m/z calculated. It 
yielded a molecule with m/z 593, what may have happened is that the conjugated 
compound fragmented easily. This means that, the reaction needed optimization to yield the 
conjugated molecule and to make it more stable and MS cone voltage should have been 
optimized to minimize in-source fragmentation. 
 
 
Figure 20: ESI-MS after click chemistry reaction without TBTA 
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Figure 21: ESI-MS/MS after click chemistry reaction without TBTA 
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The spectra shown in Figures 22 and 23 were obtained after analyzing the click chemistry 
reaction at condition at 37
o
C for 24 hr and after adding TBTA as a ligand to accelerate the 
reaction. The results confirmed that the chemistry reaction occurred and yielded the 
expected m/z of the conjugated molecule (NVP-ALK and Biotin-PEG3-Azide). 
 
 
Figure 22: ESI-MS after optimizing the reaction conditions 
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Figure 23: ESI-MS/MS analysis after optimizing the reaction conditions 
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Click reaction conditions were tested with another alkyne containing drug, Erlotinib, a drug 
used for treating cancer. The same conditions used for NVP-ALK were applied. Figure 24 
showed that, Erlotinib was effectively conjugated with Biotine-PEG3-Azide. 
 
 
Figure 24: ESI-MS analysis to confirm the condition of click chemistry reaction. 
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3.4 Detection of Proteins Modified by Nevirapine Metabolites by Western Blot 
 
Figure 25:  Extracted proteins from skin of rats treated with NVP-ALK after coupling with 
Biotin-PEG3-Azide by click chemistry reaction and detection by streptavidin-HRP 
 
Figure 25 shows the immunoblot of rat skin untreated (CTR) and treated with NVP-ALK, 
after incubation with streptavidin HRP. Streptavidin HRP was used due to its high affinity 
to Biotin. The detected proteins appeared as a smeared band.  
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3.5 Identification of Modified Protein by Nevirapine Metabolite using Mass 
Spectrometry and Protein Identification Software 
 
 
Figure 26:  Protein hits from mascot software 
 
Figure 26 shows that the recovered peptides from in-gel digestion analyzed by nLC-
MS/MS. The corresponding proteins were identified in the Rattus protein database using 
MASCOT. Figure 26 shows a list of proteins identified despite that the band was a large 
smear band, still resulting in positive protein identification. 
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Figure 27:  Peptide summary of injected sample 
 
Figure 27 shows peptides summary from two proteins identified from samples from the BN 
rats treated with NVP-ALK. The high score indicates a very high probability of correct 
protein identification.  
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Figure 28:  Fragmented peptide in the sample 
 
Figure 28 shows MS/MS fragmentation of one peptide found in sample.   
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Figure 29: Protein sequence coverage  
 
Figure 29 shows that the identified protein was keratin. Peptides from samples covered 
10% of keratin. Thus, keratin was identified as the main protein that may be modified by 
NVP-ALK metabolite. This result, however, still needs further investigation. 
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3.6 Detection of S-glutathionylated Protein 
 
   kDa 
 
 
Figure 30: Immunoblot detection of glutationylated proteins in skin fractions of rats treated 
or not with NVP-ALK (in non-reducing SDS-PAGE condition (absence of DTT)).  
CTR: untreated rats, NVP: treated rats with NVP and NVP-ALK: treated rats with NVP-
ALK 
 
In order to detect the proteins modified by glutathionylation, anti-glutathione monoclonal 
antibody (virogen) was used. It has been noted that the reactivity of the antibody depends 
upon the nature surrounding the epitope and that some glutathionylated proteins are not or 
only weakly recognized by the antibody (Brennan et al., 2006). Nevertheless, Western blot 
allows detection of glutathionylated proteins in cells and tissues under conditions of 
oxidative or nitrosactive stress, without the addition of reducing agents (DTT) (Hill et al., 
2010). 
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3.7 Identification of Glutathionylated Proteins 
Table 2: Identification of Glutathionylated Proteins  
 
 
Name N Unused Total %Cov %Cov(50) %Cov(95) 
Actin, cytoplasmic 2 
OS=Rattus 
norvegicus 
GN=Actg1 PE=1 
SV=1 
1 18.59 18.59 47.99999893 40.0000006 38.13000023 
Actin, cytoplasmic 1 
OS=Rattus 
norvegicus 
GN=Actb PE=1 
SV=1 
1 0 18.59 47.99999893 40.0000006 38.13000023 
Elongation factor 1-
alpha 1 OS=Rattus 
norvegicus 
GN=Eef1a1 PE=1 
SV=1 
2 14 14 24.4599998 20.78000009 20.78000009 
Protein 
LOC100360413 
OS=Rattus 
norvegicus 
GN=LOC100360413 
PE=4 SV=1 
2 0 12 20.99999934 17.31999964 17.31999964 
Elongation factor 1-
alpha 2 OS=Rattus 
norvegicus 
GN=Eef1a2 PE=2 
SV=1 
2 0 12 19.22000051 15.54999948 15.54999948 
Heat shock protein 
HSP 90-beta 
OS=Rattus 
norvegicus 
GN=Hsp90ab1 
PE=1 SV=4 
3 12.93 12.93 12.02000007 12.02000007 10.63999981 
Protein Hist1h2bf 
OS=Rattus 
norvegicus 
GN=Hist1h2bf PE=4 
SV=1 
4 10 10 46.02999985 40.47999978 40.47999978 
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Table 2 shows a preliminary attempt to identify the glutathionylated proteins using on-
membrane digestion, LC-ESIMS/MS and database searching (Peakview software (Sciex)). 
The identification of gutathionylated proteins (Table 2) has correctly identified several 
proteins in the gel band that were judged by WB to contain at least one glutathionylated 
protein. However, there was no MS evidence to determine which of the identified proteins 
were glutathionylated neither if there was more than one protein that was glutathionylated. 
In addition, from the results it was observed that the peptides from samples covered 38% of 
actin. Since it was not possible to obtain analytical evidence from the MS fragmentation of 
the glutathionylated peptide from actin or other proteins, further investigation is required to 
identify and confirm the glutathionylated protein(s). 
 
Furthermore, Figure 31 shows peptide summaries from sample of BN rats treated with 
NVP-ALK. The molecular weight of actin is 40 kDa but we detected it at 140 kDa. This 
can be explained by the fact that actin can bind to other proteins as ABP to form a polymer. 
Further studies are required to confirm this hypothesis. 
 
 
Figure 31: Glutathionylated protein identification by MS and sequence database searching  
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DISCUSSION 
 
HIV (Human Immune Deficiency Virus) affects millions of people around the world. The 
virus attacks the immune system in affected persons by infecting and destroying white 
blood cells called CD4+ cells. If disease is left untreated, it leads to a reduction in CD4+ 
cells and causes AIDS. 
 
Treatment of HIV will improve patient quality of life and will slow or stop the progression 
of infection and the damage to the immune system. Nevirapine (NVP) is an antiretroviral 
drug and is a non-nucleoside reverse transcriptase inhibitor. Despite its therapeutic effect, it 
has serious life threatening effects such as hepatotoxicity and skin hypersensitivity. Skin 
rash hypersensitivity is the most frequent adverse event associated with Nevirapine therapy 
and it appears to be immune-mediated. The basic mechanisms of IDRs are currently not 
well understood. Circumstantial evidence suggests that most IDRs are caused by the 
formation of reactive metabolites rather than the parent drug. Reactive metabolites 
covalently bind to proteins and cause protein modification. This modification mediates the 
immune response, which can be expressed in skin rash hypersensitivity (Uetrecht, 2008).  
 
Many researchers have tried to understand the mechanism and how these reactions occur. 
In this study, we tried to validate the hapten hypothesis, which state that Nevirapine is 
metabolized to reactive metabolites, which can bind to proteins and cause protein 
modification. This protein modification mediated an immune response, which leads to skin 
rash hypersensitivity. Sharma et al. (2013) stated that rash is caused by a metabolite of 
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NVP as it is oxidized in the liver to a benzylic alcohol (12-OH-NVP), which travels to the 
skin where it forms a reactive benzylic sulfate. As pointed out by Zhang et al. (2013), this 
could both act as a hapten and induce a danger signal. 
 
Nevirapine Alkyne (NVP-ALK), which was synthesised in Prof. Klaus Klarskov’s 
laboratory (University of Sherbrooke, Quebec) in collaboration with Prof. Y. Dory, was 
used. NVP-ALK facilitates coupling and detection of reactive NVP metabolites using click 
chemistry. Click chemistry reaction was repeated in many conditions until the optimum one 
that led to coupling of the two molecules (protein from BN rats and Biotin-PEG3-Azide) 
was confirmed and the optimum conditions were recorded. 
 
In addition, the modified proteins from BN rats treated with NVP-ALK and untreated BN 
rats (used as a control in this study) were identified. The proteins were extracted from 
whole skin. Western blot was used to detect protein bound with NVP-ALK. Streptavidin 
HRP antibody was used due to its high affinity to biotin. The following sections discuss the 
results of the tests: 
 
4.1 Nevirapine Alkyne (NVP-ALK) 
Nevirapine Alkyne (NVP-ALK) is Nevirapine analogue, which has an alkyne group in its 
molecule. This terminal alkyne group is an appropriate site for reaction with Azide 
conjugated probes using click chemistry. Defoy (2010) demonstrated that NVP-ALK 
induces similar side effects as those developed by Nevirapine. Thus, in this study we used 
NVP-ALK to induce similar side effects as those caused by Nevirapine and to be able to 
use the click chemistry technique. 
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4.2 Click Chemistry Reaction 
We used NVP-ALK to optimize click chemistry condition by coupling it with Biotin-
PEG3-azide. The most challenging part was adjusting the optimal concentration, 
temperature, incubation period and the addition of TBTA ligand. My protocol followed the 
procedure provided Presolski et al. (2011) but with some modifications. In the work 
conducted by Presolski et al. (2011) the click chemistry reaction occurred at room 
temperature. In the experiments conducted herein, however, it was not possible to detect the 
expected molecule. Changing the incubation periods from minutes to hours at the room 
temperature did not yield or confirm the click chemistry reaction and the mass did not 
match the calculated mass of NVP-ALK-Biotin-PEG3-Azide as shown in Figures 19-21.   
 
Using different concentrations of NVP-ALK and Biotin-PEG3-azide, temperature, 
incubation periods, with/without ligand and verifying the results by the mass spectrometry, 
the optimum conditions at which the click chemistry occurred were reached. The trials that 
have been conducted included a wide range for the affecting parameters, which were 
temperature (room temperature to 95
o
C), incubation period (2 hr to 24 hr), concentrations, 
the use of ligand (with and without). The optimized conditions were obtained when both 
NVP-ALK and Biotin-PEG3-Azide molecules were conjugated together. This was 
achieved at 37
o
C for an incubation period of 24 hr with a TBTA (Tris-
(benzyltriazolymethyl) amine ligand. The 37
o
C accelerated coupling of the two molecules 
and the use of TBTA as ligand influenced the reaction and yielded a molecule with a mass 
equal to the sum of NVP-ALK and Biotin-PEG3-Azide (NVP-ALK-Biotin-PEG3-Azide). 
Click chemistry reaction was confirmed using electro spray ionization mass spectrometry 
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as shown in Figures 22 and 23. The mass was equivalent to the mass of the conjugated 
molecule (NVP-ALK-Biotin-PEG3-Azide), 709 m/z, which confirms the reaction. Since 
the click chemistry reaction is known by its simplicity and selectivity, the click chemistry 
reaction takes place only between azide and alkyne components. It does not interfere with 
any other organic groups present in DNA and proteins being labeled, such as amino and 
carboxyl groups.  
 
To provide another confirmation on the click chemistry, Erlotinib was used as it has alkyne 
in its molecule, which made it react similarly to NVP-ALK in click chemistry reaction. 
After using Erlotinib at the same concentration at 37
o
C for 24 hr and using the TBTA 
ligand, it yielded the reaction as shown in Figure 24 with a m/z of 838, which correspond to 
the mass of the two conjugate molecules. 
 
4.3 Protein Identification 
Several trials were conducted using the Western blot and they yielded the same large 
smeared band. As shown in result in Figure 25, the band was more dark and pronounced at 
70 kDa to 60 kDa. The result was similar to the result obtained by another research group 
working on nevirapine hypersensitivity (Sharma et al., 2013) as they detected Nevirapine 
metabolite or derivatized proteins at the same weight with similar large smear band.  
 
One of the main objectives in this study was to identify the modified proteins by 
Nevirapine Alkyne (NVP-ALK). The recovered peptides were analyzed by nLC-MS/MS 
and the corresponding proteins were identified in the Rattus protein database using 
MASCOT. We found that peptides from our sample covered 10% of keratin. The source of 
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keratin was from the Brown Norway rats used in this study. The MS/MS data of peptides 
covering 10% of the keratin sequence is very good and is a valid identification. Knowing 
that the molecular weight (MW) of keratins in mammal’s range from 40 to 70 kDa (Sun et 
al., 1983) and that our detected protein band was at the same range, our result become more 
probable. In addition, keratin is a water insoluble protein accounting for 95% of all proteins 
present in the epidermis, which gives the epidermis, and therefore the skin itself, its 
protective function. 
 
What if keratin lost its protective function? Bragulla and Homberger (2009) discussed in 
details the functions of keratin. As mentioned above, protein modification may result in 
loss of protein function but we still do not know which function and what the role of keratin 
in hypersensitivity is. Further investigation should be done by studying this modification 
and its effect on protein function. 
 
4.4 NVP induced protein S-glutathionylation 
Our hypothesis of Nevirapine hypersensitivity suggested that drug or drug metabolites can 
cause oxidative stress, which leads to cell damage. This damage mediates immune response 
such as hypersensitivity (skin rash). Glutathione is considered as an antioxidant that 
protects cells against oxidative stress, which is the inadequacy between production of 
reactive oxygen species and the capability of an organism/cell to detoxify or to repair any 
damage to protein, lipids and DNA. There are many causes of oxidative stress such as 
disease and medication. In this study, the presence of glutathionylated proteins was used as 
an index of oxidative stress following our drug treatment.  
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Indeed, we were able to detect a glutathionylated protein namely the actin, in extracts from 
BN rats treated with NVP and NVP-ALK. Dalle-Donne et al. (2003) indicated that many 
proteins, including actin are targets for S-glutathionylation, which is the reversible 
formation of mixed disulphides between protein cysteine thiol groups and glutathione 
(GSH) that can be induced in cells by oxidative stress. 
 
The loss of reduced glutathione and the formation of glutathione disulfide is considered as 
a classical parameter of oxidative stress that is increased in diseases. Recent study (Janssen-
Heininger et al., 2013) demonstrated that glutathione plays a more direct role in biological 
and pathophysiological processes through covalent modification to reactive cysteines 
within proteins, a process known as S-glutathionylation. The formation of an S-
glutathionylated moiety within the protein can lead to structural and functional 
modifications. Temporary activation, inactivation, loss of function, and gain of function 
have all been attributed to S-glutathionylation (Janssen-Heininger et al., 2013). 
 
Our preliminary result indicated that actin was the glutathionylated protein. Actin 
glutathionylation was discussed before in literature but this is the first time that a link 
between actin glutathionylation and hypersensitivity reaction is proposed. Our results being 
only preliminary, more testing is necessary to confirm or rule out the connection between 
these two phenomena. 
4.5 What are the potential consequences associated with Actin S-glutathionylation? 
Actin is the most abundant protein in cells. It participates in more protein-protein 
interactions than any known protein and it controls a large number of actin-binding proteins 
(ABP) (Dominguez and Holmes, 2011). These properties make actin a critical player in 
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many cellular functions, ranging from cell motility and the maintenance of cell shape and 
polarity to the regulation of transcription (Dominguez and Holmes, 2011). To achieve these 
multiple cellular functions, actin polymerization, translocation, polarity, and rate of 
assembly are rigorously regulated by a large number of actin-binding proteins (ABP) as 
well as by covalent modifications that may also target the actin-binding proteins (Sheterline 
et al., 1996). 
 
Protein glutathionylation is increased as a consequence of oxidative stress, and the most 
common consequence is loss of function of proteins (Ghezzi, 2013). Determination of 
which functions of actin were affected by glutationylation needs more experimental work. 
Detecting actin at 140 kDa means that actin can bind with another protein or a group of 
proteins. We need more experiments to confirm this finding. 
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CHAPTER 5 
CONCLUSION AND PERSPECTIVE  
 
5.1 Conclusion and Perspective 
Based on the results of the experiments conducted herein and the information available 
from literature the following conclusions can be drawn: 
 
 This study confirms the effectiveness of using Nevirapine Alkyne (NVP-ALK) 
instead of Nevirapine (NVP) to facilitate the detection of nevirapine metabolite by 
click chemistry reaction in agreement with previous studies. We also found that 
NVP-ALK share similar in vivo side effects than NVP in BN rats.  
 
 Nevirapine (NVP) is metabolized to a reactive metabolite, which induces protein 
modification (see Figure 32). Our result showed that the peptides identified in the 
extracted proteins from skin BN rats treated with NVP-ALK matched 10% of 
keratin. This identification still needs further confirmation. As it is the first study to 
demonstrate that keratin could play a role in hypersensitivity, further investigations 
are needed to find out what modifications of keratin mediate an immune response 
and lead to hypersensitivity. Roth et al. (2012) stated that Keratin 1 is crucial for 
maintenance of skin integrity and participates in an inflammatory network in murine 
keratinocytes. Thus, the impact of these protein post-translational modifications on 
keratin functions should also be investigated. 
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 Nevirapine (NVP) metabolite caused an oxidative stress in cells, which could lead 
to cell damage that mediates induction the immune response. Protein 
glutathionylation through formation of mixed disulfides with glutathione (GSH) can 
affect protein characteristics/functioning (Ghezzi, 2013). This is in agreement with 
the danger hypothesis. 
 
 In the experiments conducted herein, an anti-glutathione monoclonal antibody was 
used to detect glutathionylated protein. The preliminary results detected a 
glutathionylated protein band at 140 kDa. The band seen on the western blot 
corresponded to a peptide that matches the sequence of actin, which, however, has a 
known molecular weight of 42 kDa. This higher molecular weight detected for actin 
can be attributed to the fact that it can bind to other proteins referred to as actin-
binding proteins (ADP), which can exhibit such high molecular weight. These latter 
ADP proteins are involved in actin's polymerisation, depolymerisation, stability, 
organisation in bundles or networks, fragmentation and destruction (Dominguez, 
2004). The diversity of these ADP proteins is such that actin is thought to be the 
protein that takes part in the greatest number of protein-protein interactions. We 
may conclude that NVP metabolite lead to cellular injury that leads to s-
glutathionylation as shown in Figure 32. 
 
 As discussed before, protein glutathionylation has various consequences. Further 
investigations are needed to confirm this preliminary result and to understand the 
consequences and effects of protein glutathionylation on actin functions. 
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Figure 32: Nevirapine hypersensitivity reaction  
 
 
 
 
5.2 Future Studies 
The following studies may be conducted to further investigate the topic and confirm the 
results: 
1) Separation of dermis and epidermis of rat skin treated with NVP and see if another 
protein different than keratin can be identified. 
2) More investigation to confirm the identification of actin as the primary target for s-
glutathionylation. 
3) Understanding how glutathione modifications regulate protein function. 
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